Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Intervention Indication Therapeutic Area Year Actions
Acarizax for treating allergic rhinitis or allergic rhinoconjunctivitis in children aged 5 to 11 years old Acarizax Allergic rhinitis , Allergic rhinoconjunctivitis Immunology , Ophthalmology 2024 View  |  Download
Acoramidis for symptomatic transthyretin amyloid cardiomyopathy Acoramidis (AG10) Transthyretin amyloid cardiomyopathy Cardiovascular System 2023 View  |  Download
Adagrasib for previously treated KRAS G12C mutated advanced non-small-cell lung cancer Adagrasib (MRTX-849) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Adalimumab for Dupuytren's disease Adalimumab Dupuytren's disease Musculoskeletal System 2023 View  |  Download
Adstiladrin for high-grade, BCG unresponsive non-muscle-invasive bladder cancer Adstiladrin (Nadofaragene firadenovec; rAd-IFN/Syn3; Instiladrin) Bladder cancer Urological Cancer 2019 View  |  Download
Aducanumab for mild cognitive impairment due to Alzheimer’s disease Aducanumab (BIIB037) Cognitive impairment Neurology 2020 View  |  Download
Afamitresgene autoleucel for advanced synovial sarcoma or myxoid/round cell liposarcoma ADP-A2M4 (MAGE-A4 SPEAR T-cell) Soft tissue sarcoma , Synovial sarcoma Sarcoma 2021 View  |  Download
Aflibercept for previously untreated retinopathy of prematurity in children Aflibercept Retinopathy of prematurity Gynaecology and Obstetrics , Ophthalmology 2023 View  |  Download
Alectinib adjuvant therapy for ALK-positive non-small cell lung cancer Alectinib (Alecensa) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2023 View  |  Download
Alpelisib and Olaparib for treating platinum-resistant or refractory BRCA wild-type ovarian cancer Alpelisib (BYL719; Piqray) , Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Ovarian cancer Female Reproductive Cancer 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications